Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2005
09/14/2005EP1572126A2 Compositions and methods for altering glucose production
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1013665B1 Polypeptide having water channel activity and dna sequence
09/14/2005EP1001793B1 Chromium/biotin treatment of type ii diabetes
09/14/2005EP0813543B1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/14/2005CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets
09/14/2005CN1668759A Method of searching substane having antidiabetic activity
09/14/2005CN1668755A Galactosyl isomalt, method for production and use thereof
09/14/2005CN1668728A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668631A Fractionation of phytosterol esters in oil
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668606A Oxazole derivatives and their use as insulin sensitizers
09/14/2005CN1668598A Use of chemotherapeutic agents
09/14/2005CN1668594A New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668585A 3, 6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668321A Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
09/14/2005CN1668311A Method and composition for treating diabetes
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668301A Process for producing coated preparation
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/14/2005CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
09/14/2005CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
09/14/2005CN1668285A Lasofoxifene tablet and its coating
09/14/2005CN1666986A Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof
09/14/2005CN1666751A Prescription for treating type 2 diabetes and its preparing method
09/14/2005CN1666750A Peach blossom oil and its production process
09/14/2005CN1219062C Mouse cholesterol ester synthetase-2 gene promotor
09/14/2005CN1218946C Isoquinuclidine derivative, process for producing same, and medicinal compsn. contg. same
09/14/2005CN1218945C Method for producing lipoic acid and dihydrolipoic acid
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218707C Fat-reducing and thrombolytic pill
09/14/2005CN1218704C Sodium bialginate for injection and its preparation method
09/13/2005US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943181 Use of substituted gamma-lactone compounds as pharmaceutical preparations
09/13/2005US6943176 Heterocyclic derivatives
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943171 For therapy of urological, vascular or pulmonary disorders
09/13/2005US6943160 Morpholine derivatives as antagonists of orexin receptors
09/13/2005US6943156 3-(5,6,7,8-Tetrahydro-(1,8)naphthyridin-2-yl)-ethoxy)-11H-di-b enzo(1,4)oxazepin-10-yl)-acetic acid; inhibiting bone resorption; vascular restenosis; osteoporosis; angiogenesis inhibitors; diabetic retinopathy; anticarcinogenic agents
09/13/2005US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds
09/13/2005US6943146 Control cell proliferation, cell differentiation; culture product
09/13/2005US6942857 Lactobacillus reuteri PRD202(KCTC-10301BP) which converts monosaccharides and disaccharides into intestinal nonabsorb-able polysaccharides
09/13/2005CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them
09/13/2005CA2210022C Paroxetine hydrochloride solvates
09/09/2005WO2005083070A1 Pharmaceutical composition for lowering blood sugar level
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082874A1 Novel benzothiazepine and benzothiepine compounds
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082391A1 AGONIST TO HUMAN β3 ADRENALINE RECEPTOR
09/09/2005WO2005082390A1 Fat accumulation inhibitors
09/09/2005WO2005082349A1 Composition for the treatment of obesity comprising fumagillol derivative
09/09/2005WO2005082169A1 Raw material for diet processed food and diet processed food from the raw material
09/09/2005WO2005081649A2 Preparation for reducing protein deficiency in an organism and method for the production thereof
09/09/2005WO2005056036A3 Regulation of food preference using glp-1 agonists
09/09/2005WO2005042692A3 A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
09/09/2005WO2005027973A3 Combinations of a vegf receptor inhibitor with other therapeutic agents
09/09/2005WO2004080482A8 Use of angiotensin converting enzyme (ace) inhibitors to prevent diabetes in a subject with chronic heart failure
09/09/2005WO2004064542A8 Composition for oral administration containing capsaicinoids
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2558155A1 Casein derived peptides and therapeutic uses thereof
09/09/2005CA2558106A1 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2557151A1 Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity
09/09/2005CA2556923A1 Methods of treating obesity or diabetes using nt-4/5
09/09/2005CA2556914A1 Amines and amides for the treatment of diseases
09/09/2005CA2556064A1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
09/09/2005CA2554435A1 Oral dieting composition comprising conjugated linoleic acid and caffeine
09/08/2005US20050197395 Compositions and methods for body weight management
09/08/2005US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same
09/08/2005US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
09/08/2005US20050197372 Use of valsartan or its metabolite to inhibit platelet aggregation
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197288 Administering GH-releasing factor (GRF) and analogs (hexenoyl trans-3)hGRF(1-44)NH2 for altering a lipid parameter
09/08/2005US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening
09/08/2005US20050196474 Supplement foods and pharmaceuticals
1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 1298